2025-04-29

Bitcoin’s Bull Run & the AI Arms Race: What You Need to Know w/ Salim Ismail | EP #166 [REUPLOAD]

Peter Diamandis and Salim Ismail open with China's all-in robotics push versus the West's slower rollout, then dig into frontier-model IQ benchmarks and why Gemini 2.5 leads on performance while OpenAI dominates on revenue thanks to ChatGPT's 'user interface moment.' A clip of Demis Hassabis and commentary from Dario Amodei anchor a segment on AI-accelerated medicine and longevity, including Peter's own diagnostic, microbiome, and skincare stack. The pair cover Anthropic's values-in-the-wild study, Thinking Machines Lab's record $2B seed round, Google's shift toward real-world experiential training data, and the AI 2027 forecasting paper's US-vs-China bioweapon and abundance scenarios. They close on Bitcoin's push back above $90,000 and Peter's long-held binary, HODL-and-hold thesis.

▶ Watch on YouTube

Topics

China vs US robotics race Robotics ▶ 1:35
Peter contrasts a Beijing airport robot showcase with fashion ads at JFK, and Salim argues China is racing to automate its workforce ahead of a demographic crunch.
AI IQ benchmarks vs human intelligence AI ▶ 3:56
Peter shows a chart plotting frontier models (o3 ~133, Gemini 2.5 ~127, Claude 3 at 101 eighteen months ago) against the human IQ bell curve, debating what IQ even captures once models exceed Mensa-genius level.
Humanity's Last Exam and the AI leaderboard AI ▶ 7:47
Discussion of an AI benchmark testing reasoning across obscure academic fields, with Gemini 2.5 leading most performance metrics while OpenAI dominates on revenue.
OpenAI's revenue lead and the user-interface moment AI ▶ 11:06
Peter and Salim unpack why OpenAI monetizes better despite Google's technical lead, crediting ChatGPT as a 'user interface moment' akin to Mosaic, the iPhone, and Coinbase that made a complex technology instantly usable.
AI, DeepMind, and the end of disease Longevity ▶ 17:10
A 60 Minutes clip of Demis Hassabis describing AI-driven drug discovery timelines shrinking from years to weeks, and the pair's take on wearable-driven, real-time AI diagnosis.
Peter's personal longevity stack Longevity ▶ 22:54
Peter details three products he personally uses to extend healthspan: Fountain's full-body diagnostic upload, Viome's microbiome metatranscriptomics testing, and the OneSkin peptide for senescent skin cells.
Anthropic's values-in-the-wild study AI ▶ 27:20
A study of 700,000 anonymized Claude conversations surfaced five broad value categories (helpfulness, accuracy, empathy, safety, authenticity), which Peter and Salim read as evidence AI can carry a consistent moral code.
Constitutional alignment and geopolitical rivalry AI ▶ 30:00
Salim floats training AI on the US Constitution plus UN human rights documents to solve alignment, while Peter raises the open question of what founding documents China or Russia will train their own AI on.
Thinking Machines Lab's record seed round Economy ▶ 30:49
Mira Murati's Thinking Machines Lab raised $2B at a $10B valuation, double what she originally sought two months earlier, prompting a debate on fundraising discipline versus froth.
Training AI on real-world and deep-web data AI ▶ 34:38
A Google paper argues AI is outgrowing human-made data; Peter and Salim discuss Google and xAI's unique access to street view, YouTube, Gmail, X, and Tesla data, plus the untapped deep web.
The AI 2027 scenario paper AI ▶ 37:11
Peter walks through a forecasting paper imagining a US ('OpenBrain') vs China ('DeepCent') AI race that splits into a 'go fast' path ending in a bioweapon catastrophe and a 'slow down' path ending in aligned abundance.
Bitcoin's bull run Crypto/Web3 ▶ 44:48
With Bitcoin back above $90,000, Peter restates his binary thesis (zero or past $1M) and his 'HODL as forced savings' approach, while Salim notes recent growth spikes rewarded only those already holding.

Predictions made

open Salim Ismail: China will keep mass-deploying robots to automate its workforce because its population decline will leave too few workers within the next decade or two.
· due: 2045 · ▶ watch
“they actually need the robots to automate the workforce otherwise there won't be anybody left to do the work”
Your call:
open Demis Hassabis (clip): AI will shrink drug-design timelines from years and billions of dollars down to months or even weeks.
· due: unspecified · ▶ watch
“we could maybe reduce that down from years to maybe months or maybe even weeks”
Your call:
open Demis Hassabis (clip): AI will help bring about the end of most disease.
· due: 2035 · ▶ watch
“I think one day maybe we can cure all disease with the help of AI”
Your call:
open Dario Amodei (clip): AI could double the human lifespan.
· due: 2035 · ▶ watch
“being able to double the human lifespan potentially in the next 5 to 10 years”
Your call:
open Peter Diamandis: Bitcoin will either collapse to zero or climb past one million dollars, with no real middle outcome.
· due: unspecified · ▶ watch
“either Bitcoin goes to zero, it goes through a million dollars of Bitcoin, there's no real middle ground”
Your call:
open Peter Diamandis: Bitcoin is set up for a monster bull run based on its price hitting Fibonacci-sequence support levels.
· due: 2025 · ▶ watch
“we're getting ready for a monster bull run in Bitcoin”
Your call:

Numbers that matter

Worth digging into

🕳️ The AI 2027 scenario paper (OpenBrain vs DeepCent)
A detailed, choose-your-own-adventure forecast from AI policy experts mapping both a bioweapon-catastrophe path and an aligned-abundance path by 2030 — a concrete model for what 'fast takeoff' could actually look like.
🕳️ Anthropic's 700,000-conversation values study
First large-scale empirical look at what values a deployed LLM actually exhibits in the wild, not just what it's trained to say.
🕳️ Colossal's de-extinction tooling and embedded ethics teams
The dire-wolf project is a minor headline next to the real story: a generalizable DNA-editing tool set, paired with a standing ethics review on every project, that's directly transferable to human disease editing.
🕳️ Viome's metatranscriptomics, born from Los Alamos biodefense research
An unusual technology lineage, from nuclear-bomb-era biodefense science to personalized nutrition, that's worth understanding before recommending the product.